Abstract: An anti-tampering apparatus and method for drug delivery devices provides for the capture of caps in a manner that restricts repositioning of a captured cap onto a corresponding drug delivery device. The anti-tampering apparatus includes one or more retention members to define a capture region for restrainably capturing a cap. The anti-tampering apparatus further locates an obstruction surface thereof to engage a surface of a drug delivery device and thereby restrict recapping of the device by the captured cap. As such, tampering of a drug delivery device is indicated by the absence of a cap captured within the anti-tampering apparatus.

Abstract: An anti-tampering apparatus and method for drug delivery devices provides for the capture of caps in a manner that restricts repositioning of a captured cap onto a corresponding drug delivery device. The anti-tampering apparatus includes one or more retention members to define a capture region for restrainably capturing a cap. The anti-tampering apparatus further locates an obstruction surface thereof to engage a surface of a drug delivery device and thereby restrict recapping of the device by the captured cap. As such, tampering of a drug delivery device is indicated by the absence of a cap captured within the anti-tampering apparatus.

Abstract: An anti-tampering apparatus and method for drug delivery devices provides for the capture of caps in a manner that restricts repositioning of a captured cap onto a corresponding drug delivery device. The anti-tampering apparatus includes one or more retention members to define a capture region for restrainably capturing a cap. The anti-tampering apparatus further locates an obstruction surface thereof to engage a surface of a drug delivery device and thereby restrict recapping of the device by the captured cap. As such, tampering of a drug delivery device is indicated by the absence of a cap captured within the anti-tampering apparatus.

Abstract: A system is provided for use and handling a medical liquid (e.g. hazardous drugs) that includes a transfer adapter having a port rotatably interconnectable to a male luer fitting of a needleless syringe or infusion tubing line port, and a patient connector having a port rotatable interconnectable to a female luer fitting of an intravascular catheter access port. Ports of the transfer adapter and patient connector are interconnectable to automatically define a closed fluid passageway. A vial adapter and/or a reservoir adapter may be provided for selective interconnection to the transfer adapter wherein a second closed fluid passageway and/or a third closed fluid passageway are automatically defined upon interconnection with the transfer adapter.